IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity.
Lv K, Hu B, Xu M, Wan L, Jin Z, Xu M, Du Y, Ma K, Lv Q, Xu Y, Lei L, Gong H, Liu H, Wu D, Liu Y.
Lv K, et al.
Exp Hematol Oncol. 2022 Jun 2;11(1):34. doi: 10.1186/s40164-022-00286-x.
Exp Hematol Oncol. 2022.
PMID: 35655245
Free PMC article.